Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A
出版年份 2021 全文链接
标题
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A
作者
关键词
-
出版物
SCIENCE
Volume 371, Issue 6532, Pages 926-931
出版商
American Association for the Advancement of Science (AAAS)
发表日期
2021-02-26
DOI
10.1126/science.abf4058
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Multiple myeloma: 2020 update on diagnosis, risk‐stratification and management
- (2020) S. Vincent Rajkumar AMERICAN JOURNAL OF HEMATOLOGY
- A Genomic Perspective on the Origin and Emergence of SARS-CoV-2
- (2020) Yong-Zhen Zhang et al. CELL
- Design of Development Candidate eFT226, a First in Class Inhibitor of Eukaryotic Initiation Factor 4A RNA Helicase
- (2020) Justin T. Ernst et al. JOURNAL OF MEDICINAL CHEMISTRY
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
- (2020) Yeming Wang et al. LANCET
- Proteomics of SARS-CoV-2-infected host cells reveals therapy targets
- (2020) Denisa Bojkova et al. NATURE
- A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
- (2020) David E. Gordon et al. NATURE
- The proximal origin of SARS-CoV-2
- (2020) Kristian G. Andersen et al. NATURE MEDICINE
- SynergyFinder 2.0: visual analytics of multi-drug combination synergies
- (2020) Aleksandr Ianevski et al. NUCLEIC ACIDS RESEARCH
- Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection
- (2020) Yanwen Liang et al. Frontiers in Immunology
- Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing
- (2020) Laura Riva et al. NATURE
- Drug treatments for covid-19: living systematic review and network meta-analysis
- (2020) Reed AC Siemieniuk et al. BMJ-British Medical Journal
- Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19
- (2020) Christoph D. Spinner et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function
- (2020) Emma S. Winkler et al. NATURE IMMUNOLOGY
- Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms
- (2020) David E. Gordon et al. SCIENCE
- Effect of remdesivir on patients with COVID-19: A network meta-analysis of randomized control trials
- (2020) Yujiro Yokoyama et al. VIRUS RESEARCH
- Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection
- (2020) Raveen Rathnasinghe et al. Emerging Microbes & Infections
- Randomized phase III study (ADMYRE) of plitidepsin in combination with dexamethasone vs. dexamethasone alone in patients with relapsed/refractory multiple myeloma
- (2019) Ivan Spicka et al. ANNALS OF HEMATOLOGY
- Aplidin (plitidepsin) is a novel anti-myeloma agent with potent anti-resorptive activity mediated by direct effects on osteoclasts
- (2019) Jesus Delgado-Calle et al. Oncotarget
- Derivation of self-renewing lung alveolar epithelial type II cells from human pluripotent stem cells
- (2019) Anjali Jacob et al. Nature Protocols
- Strain-Specific Contribution of Eukaryotic Elongation Factor 1 Gamma to the Translation of Influenza A Virus Proteins
- (2018) Shuhei Sammaibashi et al. Frontiers in Microbiology
- Plitidepsin: a potential new treatment for relapsed/refractory multiple myeloma
- (2018) Michael Leisch et al. Future Oncology
- Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
- (2017) Timothy P. Sheahan et al. Science Translational Medicine
- Further Evidence for Bats as the Evolutionary Source of Middle East Respiratory Syndrome Coronavirus
- (2017) S. J. Anthony et al. mBio
- Targeting Viral Proteostasis Limits Influenza Virus, HIV, and Dengue Virus Infection
- (2016) Nicholas S. Heaton et al. IMMUNITY
- SARS and MERS: recent insights into emerging coronaviruses
- (2016) Emmie de Wit et al. NATURE REVIEWS MICROBIOLOGY
- SARS-like WIV1-CoV poised for human emergence
- (2016) Vineet D. Menachery et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nannocystin A: an Elongation Factor 1 Inhibitor from Myxobacteria with Differential Anti-Cancer Properties
- (2015) Philipp Krastel et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence
- (2015) Vineet D Menachery et al. NATURE MEDICINE
- Bat origin of human coronaviruses
- (2015) Ben Hu et al. Virology Journal
- Ternatin and improved synthetic variants kill cancer cells by targeting the elongation factor-1A ternary complex
- (2015) Jordan D Carelli et al. eLife
- The eEF1A Proteins: At the Crossroads of Oncogenesis, Apoptosis, and Viral Infections
- (2015) Wasim Abbas et al. Frontiers in Oncology
- The Eukaryotic Elongation Factor 1A Is Critical for Genome Replication of the Paramyxovirus Respiratory Syncytial Virus
- (2014) Ting Wei et al. PLoS One
- EF1A interacting with nucleocapsid protein of transmissible gastroenteritis coronavirus and plays a role in virus replication
- (2014) Xin Zhang et al. VETERINARY MICROBIOLOGY
- Human iPS cell–derived alveolar epithelium repopulates lung extracellular matrix
- (2013) Mahboobe Ghaedi et al. JOURNAL OF CLINICAL INVESTIGATION
- The Unexpected Roles of Eukaryotic Translation Elongation Factors in RNA Virus Replication and Pathogenesis
- (2013) D. Li et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- Ad5:Ad48 Hexon Hypervariable Region Substitutions Lead to Toxicity and Increased Inflammatory Responses Following Intravenous Delivery
- (2012) Lynda Coughlan et al. MOLECULAR THERAPY
- The cytotoxic activity of Aplidin in chronic lymphocytic leukemia (CLL) is mediated by a direct effect on leukemic cells and an indirect effect on monocyte-derived cells
- (2011) Pablo E. Morande et al. INVESTIGATIONAL NEW DRUGS
- Development and RNA-Synthesizing Activity of Coronavirus Replication Structures in the Absence of Protein Synthesis
- (2011) S. H. E. van den Worm et al. JOURNAL OF VIROLOGY
- Plitidepsin Has a Safe Cardiac Profile: A Comprehensive Analysis
- (2011) Arturo Soto-Matos et al. Marine Drugs
- Phase I study of weekly plitidepsin as 1-hour infusion combined with carboplatin in patients with advanced solid tumors or lymphomas
- (2010) Ramón Salazar et al. INVESTIGATIONAL NEW DRUGS
- In Vivo Retargeting of Adenovirus Type 5 to v 6 Integrin Results in Reduced Hepatotoxicity and Improved Tumor Uptake following Systemic Delivery
- (2009) L. Coughlan et al. JOURNAL OF VIROLOGY
- (−)-Ternatin inhibits adipogenesis and lipid metabolism in 3T3-L1 cells
- (2009) Masahiko Ito et al. PEPTIDES
- Population pharmacokinetics meta-analysis of plitidepsin (Aplidin®) in cancer subjects
- (2008) Ricardo Nalda-Molina et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Aplidin, a Marine Organism-Derived Compound with Potent Antimyeloma Activity In vitro and In vivo
- (2008) C. S. Mitsiades et al. CANCER RESEARCH
- Proteomics Analysis Unravels the Functional Repertoire of Coronavirus Nonstructural Protein 3
- (2008) B. W. Neuman et al. JOURNAL OF VIROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation